Tags |
|
|
Links |
|
|
Top Articles - Investing - Hype-Proof Your Portfolio
My most recent article criticizing the controversial equity-indexed annuity has generated a boatload of email. But one email in particular caught my eye. And it wasn’t from being flamed by irate insuran
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ce agents (I got plenty of those!), or emails from thankful consumers, pleased the public is being warned about equity-indexed annuities’ pitfalls.
This special email was from a California lady who had
This special email was from a California lady who had
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
just attended a free dinner promoting equity-indexed annuities. Being a legal assistant, she was able to sift through the fine print found on annuity contracts and to actually understand it. She quickly
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
realized what the salesman presented didn’t line up with the contract. When questioned, he told her that no, what he was saying was true.
After she got home, she contacted the insurance company direct
After she got home, she contacted the insurance company direct
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
y, and they confirmed her suspicions: the salesman was misrepresenting the facts. The fine print was correct, not his sales pitch. In her email to me, she asked a very important question: How can invest
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
rs protect themselves from being taken by slick salespeople?
First of all, investors have to learn to separate the message from the messenger. Financial salespeople are highly trained to hit consumers’
First of all, investors have to learn to separate the message from the messenger. Financial salespeople are highly trained to hit consumers’
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
hot-buttons and overcome their objections. And let’s face it, some of them are pretty good at it! They seem genuine and you want to trust them. But you’ve got to look past the charisma and objectively
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
xamine the investment he’s pushing.
Many investors make the mistake of investing with someone purely because they play golf together or attend the same church. Again, focus on the message, not the mess
Many investors make the mistake of investing with someone purely because they play golf together or attend the same church. Again, focus on the message, not the mess
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
enger. Don’t assume expertise just because you know someone.
Second, don’t put your money into an investment that you don’t understand. As Warren Buffet says, if you can’t explain it to a child in a fe
Second, don’t put your money into an investment that you don’t understand. As Warren Buffet says, if you can’t explain it to a child in a fe
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
sentences you probably shouldn’t buy it. Today’s packaged products sound simple, but pages and pages of fine print often reveal they are very complex. If you can’t read the fine print and fully underst
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
nd it, don’t buy it.
I can’t tell you how many times I’ve heard investors say, “He said after a few years I could get my money out. But he didn’t tell me I’d have to pay thousands in surrender charges
I can’t tell you how many times I’ve heard investors say, “He said after a few years I could get my money out. But he didn’t tell me I’d have to pay thousands in surrender charges
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
to do it!” When you sign the paperwork for an investment, you are saying that you understand it, are aware of its risks and that you accept them. Moreover, you generally are relieving the advisor of his
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
her liability in the transaction, regardless of whether the sales pitch was accurate or not.
Third, never give in to pressure to make a decision right away. If an investment is good today, it will be g
Third, never give in to pressure to make a decision right away. If an investment is good today, it will be g
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ood tomorrow and next month. You should never be forced to hurry a decision to take advantage of a limited-time bonus or some other ‘act now’ offer. These are just tactics to push investors into making
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
buying decision.
One of the most vulnerable times for investors is when they move money from a company retirement program to an IRA. Most feel pressure to make a decision right away. But even then, yo
One of the most vulnerable times for investors is when they move money from a company retirement program to an IRA. Most feel pressure to make a decision right away. But even then, yo
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
can always park your money in an IRA money market account and take your time to make an informed investment decision.
Fourth, do the research. If you aren’t willing to take a few hours of your time to
Fourth, do the research. If you aren’t willing to take a few hours of your time to
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
investigate an investment, you have no business putting your money into it. The Internet makes this easy. Look for negative information about a product. See if the reasons are valid. Make sure you get
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ll the information, not just what the advisor tells you.
Fifth, if you’re planning to put your money into an investment type that’s new to you, move into it slowly. Don’t jump in all at once. You can a
Fifth, if you’re planning to put your money into an investment type that’s new to you, move into it slowly. Don’t jump in all at once. You can a
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
lways add more to that type of investment later.
Last of all, whatever investment choice you make, you won’t know if it’s the right one until further down the road. So make sure you won’t have to pay a
Last of all, whatever investment choice you make, you won’t know if it’s the right one until further down the road. So make sure you won’t have to pay a
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
big surrender charge if you need to change your mind later.
Don’t be fooled by the hype. If it sounds too good to be true it probably is. Follow these steps and you will increase your chance of success
Don’t be fooled by the hype. If it sounds too good to be true it probably is. Follow these steps and you will increase your chance of success
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/102040/toparticles-Investing---HypeProof-Your-Portfolio.html">Investing - Hype-Proof Your Portfolio</a>
BB link (for phorums):
[url=http://www.toparticles.org.ua/article/102040/toparticles-Investing---HypeProof-Your-Portfolio.html]Investing - Hype-Proof Your Portfolio[/url]
Related Articles:
Franchise Opportunity Tips (Part 2)
Web Statistics for the Dense (Part 1: Sales)
Finding Cheap Bankruptcy Lawyers For You
Bookmark it:
|